Wednesday, 16 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14398
Articles
Company
Novo Nordisk Appoints Yan Cai as Greater China President Amid LeadershipChange
February 2, 2026
Company
Drug
China Medical’s Opzelura Cream Gets NMPA Approval for Vitiligo
January 30, 2026
Company
Drug
Zhaoke Ophthalmology’s Yuvezzi Gets FDA Nod for Presbyopia
January 30, 2026
Company
Drug
CSPC’s SYS 6055 CAR-T Gets NMPA Nod for Lymphoma Trials
January 30, 2026
Company
AstraZeneca Commits $14.4B China Investment in Cell Therapy Push
January 30, 2026
Drug
Ascletis ASC40 Phase III Success in Acne Vulgaris
January 30, 2026
Company
Thermo Fisher Reports Q4 Revenue Growth on AI Innovation
January 30, 2026
Company
Drug
TYK Medicines Asandeutertinib Gets China Priority Review for NSCLC Brain Metastases
January 30, 2026
Company
Takeda Q3 Revenue Drops 3.3% on VYVANSE Generics, Raises Full-Year Forecast
May 14, 2026
Company
Deals
Tyligand Bio Files Hong Kong IPO with Phase II KRAS G12D Inhibitor TSN1611
January 30, 2026
Company
Drug
Hengrui Cancer Combo Gets NMPA Nod for Liver Cancer Trials
April 21, 2026
Company
Deals
Genhouse Bio Files Hong Kong IPO with Phase II SHP2 Inhibitor GH21
January 30, 2026
1
2
…
172
173
174
175
176
…
1,199
1,200
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?